Clinical Trial

TRU-Cut Biopsy in Tumor cHaracterisation

Study acronym: TRUTH
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 10, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Tru-cut biopsy (TCB) is a minimally invasive method to get an adequate sample from the lesion in order to tailor the appropriate management avoiding unnecessary surgery. The aim of our trial is to evaluate the adequacy, accuracy and safety of the method related to the final histology as reference standard.
Trial Details
NCT Number NCT06816160
Lead Sponsor General University Hospital, Prague
Conditions Tumor
Enrollment 250 participants
Start Date 2024-02-01
Primary Completion 2026-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-10